Pro-Dex, Inc.
NASDAQ Capital MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Richard Lee Van Kirk Jr.
- Full Time Employees
- 146
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Address
- 2361 McGaw Avenue Irvine CA United States of America 92614
- IPO Date
- Aug 7, 1986
- CIK
- 0000788920
- Website
- pro-dex.com
- Similar Companies
- Business
- Pro-Dex, Inc. (NasdaqGS:PDEX) designs, develops, manufactures and sells powered surgical instruments primarily for medical device original equipment manufacturers worldwide; offers autoclavable, battery-powered and electric multi-function surgical drivers and shavers used in orthopedic, thoracic and craniomaxillofacial markets, as well as rotary air motors for medical, aerospace, industrial automation and other industries; and provides engineering, quality, regulatory consulting, contract manufacturing, assembly, testing and prototyping services to hospitals, medical engineering labs, scientific research facilities and high-tech manufacturing operations. The company operates from ISO 13485-certified facilities in Irvine and Tustin, California, serving customers including leading providers of medical, dental, neurosurgery, spine, energy, aerospace and defense products. Founded in 1978 and headquartered at 2361 McGaw Avenue, Irvine, California 92614, Pro-Dex maintains full vertical integration from 510(k) filings and precision machining to product engineering and compliance management. In fiscal 2025, net sales increased 17% to $53.8 million driven by higher-margin next-generation handpieces and repair services, with gross margins expanding despite a transition to multiple-facility operations; fiscal 2026 first-quarter net sales rose 24% to $18.5 million; and the company hired a new Director of Operations to support ongoing expansion while shipping production volumes of advanced surgical handpieces.
Pro-Dex: Still A Buy, But Don't Chase
Pro-Dex, Inc. Announces Fiscal 2026 Third Quarter and Nine Month Results
Pro-Dex (NASDAQ:PDEX) Stock Price Passes Above 200 Day Moving Average – Should You Sell?
Pro-Dex, Inc. Announces Acquisition of Advanced Precision Machining
Pro-Dex, Inc. Announces Fiscal 2026 Second Quarter and Six-Month Results
Head-To-Head Contrast: Pro-Dex (NASDAQ:PDEX) vs. STAAR Surgical (NASDAQ:STAA)
Pro-Dex: A Niche Surgical Tools Microcap Trading At A Discount
D.A. Davidson & CO. Increases Holdings in Pro-Dex, Inc. $PDEX
Pro-Dex Valuation Is Attractive Despite Customer Risk
Head to Head Survey: Cardinal Health (NYSE:CAH) vs. Pro-Dex (NASDAQ:PDEX)
Head-To-Head Review: Pro-Dex (NASDAQ:PDEX) & Spotlight Innovation (OTCMKTS:STLT)
Pro-Dex, Inc. Announces Contract Extension With Largest Customer
Head to Head Contrast: Spotlight Innovation (OTCMKTS:STLT) versus Pro-Dex (NASDAQ:PDEX)
Head to Head Review: Pro-Dex (NASDAQ:PDEX) vs. Lifevantage (NASDAQ:LFVN)
Pro-Dex, Inc. (PDEX) Q1 Earnings and Revenues Top Estimates
Pro-Dex, Inc. Announces Fiscal 2026 First Quarter Results
D.A. Davidson & CO. Purchases New Position in Pro-Dex, Inc. $PDEX
Pro-Dex, Inc. Announces Clarification Related to Trading Symbol
Pro-Dex, Inc. (PDEX) Lags Q4 Earnings and Revenue Estimates
Pro-Dex, Inc. Announces Fiscal 2025 Fourth Quarter and Full-Year Results